SUTRO BIOPHARMA, INC. Debt Instrument, Interest Rate During Period
SUTRO BIOPHARMA, INC. (STRO) reported Debt Instrument, Interest Rate During Period of 11.49% for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2024-03-25
- SUTRO BIOPHARMA, INC. debt instrument, interest rate during period for the quarter ending 2023-09-30 was 11.76%, a 36.27% increase year-over-year.
- SUTRO BIOPHARMA, INC. debt instrument, interest rate during period for the quarter ending 2023-06-30 was 11.44%, a 41.76% increase year-over-year.
- SUTRO BIOPHARMA, INC. debt instrument, interest rate during period for the quarter ending 2023-03-31 was 10.95%, a 35.69% increase year-over-year.
- SUTRO BIOPHARMA, INC. debt instrument, interest rate during period for the quarter ending 2022-09-30 was 8.63%, a 6.94% increase year-over-year.
- SUTRO BIOPHARMA, INC. debt instrument, interest rate during period for fiscal 2023 was 11.49%, a 31.77% increase from fiscal 2022.
- SUTRO BIOPHARMA, INC. debt instrument, interest rate during period for fiscal 2022 was 8.72%, a 8.05% increase from fiscal 2021.
- SUTRO BIOPHARMA, INC. debt instrument, interest rate during period for fiscal 2021 was 8.07%, a 0.12% decline from fiscal 2020.
- SUTRO BIOPHARMA, INC. debt instrument, interest rate during period for fiscal 2020 was 8.08%, a 7.34% decline from fiscal 2019.
| Period end | Debt Instrument, Interest Rate During Period 3 month | Debt Instrument, Interest Rate During Period 6 month | Debt Instrument, Interest Rate During Period 9 month | Debt Instrument, Interest Rate During Period 12 month |
|---|---|---|---|---|
| 2023-12-31 | 11.49% 10-K · filed 2024-03-25 | |||
| 2023-09-30 | 11.76% 10-Q · filed 2023-11-13 | 11.38% 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | 11.44% 10-Q · filed 2023-08-10 | 11.19% 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | 10.95% 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | 8.72% 10-K · filed 2024-03-25 | |||
| 2022-09-30 | 8.63% 10-Q · filed 2023-11-13 | 8.26% 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | 8.07% 10-Q · filed 2023-08-10 | 8.07% 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | 8.07% 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | 8.07% 10-K · filed 2024-03-25 | |||
| 2021-09-30 | 8.07% 10-Q · filed 2022-11-08 | 8.07% 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | 8.07% 10-Q · filed 2022-08-08 | 8.07% 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | 8.07% 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | 8.08% 10-K · filed 2023-03-30 | |||
| 2020-09-30 | 8.07% 10-Q · filed 2021-11-10 | 8.08% 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | 8.07% 10-Q · filed 2021-08-09 | 8.08% 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | 8.09% 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | 8.72% 10-K · filed 2022-02-28 | |||
| 2019-09-30 | 8.64% 10-Q · filed 2020-11-05 | 8.80% 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | 8.87% 10-Q · filed 2020-08-06 | 8.88% 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 8.90% 10-Q · filed 2020-05-11 | |||
| 2018-12-31 | 8.39% 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 |